Cargando…
CRISPR/Cas9: A Powerful Strategy to Improve CAR-T Cell Persistence
As an emerging treatment strategy for malignant tumors, chimeric antigen receptor T (CAR-T) cell therapy has been widely used in clinical practice, and its efficacy has been markedly improved in the past decade. However, the clinical effect of CAR-T therapy is not so satisfying, especially in solid...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418799/ https://www.ncbi.nlm.nih.gov/pubmed/37569693 http://dx.doi.org/10.3390/ijms241512317 |